Damora Therapeutics, Inc. (NASDAQ: DMRA) — Healthcare · Share Price, Chart & Market Data
About: Damora Therapeutics, Inc., a biopharmaceutical company, develops therapies for the treatment of hematologic disorders in Denmark and North America. The company's lead product includes DMR-001, a investigational monoclonal antibody therapy that targets mutations in CALR, for the treatment of essential thrombocythemia; and DMR-002 and DMR-003, both anti-mutCALR-based therapies, with the intent to ultimately address the full spectrum of mutCALR MPN patients. It also develops GB3226, a small molecule inhibitor of ENL-YEATS and FLT3 for the treatment of acute myeloid leukemia. Damora Therapeutics, Inc. was founded in 2011 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $23.93 (-1.24%)
DMRADamora Therapeutics, Inc.
Loading watchlist status…
Trade DMRA now
Damora Therapeutics, Inc. share price
DMRA price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 3:01 am GMT+0
DMRA price performance
-5.862%
5D
-1.401%
1M
9.67%
YTD
792.91%
1Y
DMRA price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 3:01 am GMT+0
DMRA details
DMRA Market Signals